EVALUATION OF THE DRUG INTERACTION POTENTIAL OF PRACINOSTAT, A NOVEL HISTONE DEACETYLASE (HDAC) INHIBITOR, WITH CYP1A2 INDUCER CIGARETTE SMOKING AND CIPROFLOXACIN, A CYP1A2 INHIBITOR
EHA Learning Center, Alberto Bernareggi,
215302
A PHASE I, MULTICENTER, OPEN-LABEL DOSE-ESCALATION STUDY OF CC-122, A NOVEL CEREBLON-MODULATING AGENT, IN ADULT JAPANESE PATIENTS WITH ADVANCED NON-HODGKIN LYMPHOMA OR SOLID TUMOR
EHA Learning Center, Kazuhito Yamamoto,
215352
OVERALL SURVIVAL OF MANTLE CELL LYMPHOMA (MCL) PATIENTS HAS BEEN SIGNIFICANTLY IMPROVED DURING THE TIME, MAINLY DUE TO THE RITUXIMAB MAINTENANCE IN ELDERLY POPULATION, REAL WORLD DATA.
EHA Learning Center, Marek Trneny,
215496
CARFILZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE IN TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PRELIMINARY RESULT OF SGHMM1 TRIAL, HIGH-RISK COHORT (NCT02217163)
EHA Learning Center, Chandramouli Nagarajan,
215596